Page last updated: 2024-12-06

dansylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Dansylglycine (Dns-Gly) is a fluorescent derivative of glycine. It is synthesized by reacting dansyl chloride (a fluorescent dye) with glycine. Dansylglycine is used as a fluorescent probe in various biological and chemical applications, including:
* **Protein sequencing**: Dansylglycine is used to label the N-terminal amino acid of peptides and proteins, enabling their identification and sequencing.
* **Immunofluorescence**: Dansylglycine can be conjugated to antibodies or other molecules to visualize their distribution in cells or tissues.
* **Fluorescent labeling**: Dansylglycine can be used to label other molecules or materials to study their properties or interactions.
* **Research on enzyme activity**: Dansylglycine can be used as a substrate for some enzymes, allowing researchers to study their activity and specificity.
* **Study of protein folding**: Dansylglycine can be used to study the folding and unfolding of proteins, providing insights into their structure and function.
* **Fluorescence microscopy**: Dansylglycine is a versatile fluorescent label for microscopy applications. It emits a bright blue fluorescence, making it suitable for various imaging techniques.
Dansylglycine is studied due to its fluorescent properties, which allow for sensitive detection and visualization of molecules and processes in biological systems. Its applications are broad and continue to be explored in various fields, including biochemistry, cell biology, and biophysics.'

Cross-References

ID SourceID
PubMed CID70666
CHEMBL ID343297
SCHEMBL ID386439
MeSH IDM0116099

Synonyms (42)

Synonym
dansylglycine
nsc626927
nsc-626927
2-[[5-(dimethylamino)-1-naphthyl]sulfonylamino]acetic acid
(((5-(dimethylamino)-1-naphthyl)sulfonyl)amino)acetic acid
1091-85-6
dansylglycine, fluorescent amino acid
CHEMBL343297
2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]acetic acid
dns-gly-oh
D1501
n-[5-(dimethylamino)naphthalene-1-sulfonyl]glycine
A801976
nsc 626927
dansyl-gly
n-((5-(dimethylamino)-1-naphthyl)sulphonyl)glycine
einecs 214-129-7
FT-0624421
2-(5-(dimethylamino)naphthalene-1-sulfonamido)acetic acid
SCHEMBL386439
AKOS016674318
5-dimethylaminonaphthalene-1-sulfonyl-glycine
glycine, n-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]-
dansyl glycine
(([5-(dimethylamino)-1-naphthyl]sulfonyl)amino)acetic acid #
DTXSID00148815
mfcd00037734
(5-dimethylaminonaphthalene-1-sulfonylamino)ethanoic acid
AS-70382
2-[5-(dimethylamino)naphthalene-1-sulfonamido]acetic acid
CS-0201683
dansyl-glycine
((5-(dimethylamino)naphthalen-1-yl)sulfonyl)glycine
D5406
dansylglycine [for albumin binding assay]
T70073
HY-W141889
[1-(dimethylamino)naphthalene-5-sulfonyl]glycine
n-dansylglycine
dns-glycine
n-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]glycine
2QF9N67QFL

Research Excerpts

Overview

Dansylglycine is a weak acid that permeates as an electrically neutral species. The flux of dye across the bilayer is strongly dependent on the degree of protonation of the dye's moiety.

ExcerptReferenceRelevance
"Dansylglycine is a weak acid that permeates as an electrically neutral species; the flux of dye across the bilayer is thus strongly dependent on the degree of protonation of the dye's carboxylate moiety."( Use of the fluorescent weak acid dansylglycine to measure transmembrane proton concentration gradients.
Bramhall, J, 1986
)
1.27

Bioavailability

ExcerptReferenceRelevance
"It is important to characterize drug-albumin binding during drug discovery and lead optimization as strong binding may reduce bioavailability and/or increase the drug's in vivo half-life."( Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
Larive, CK; Lucas, LH; Price, KE, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID91481Binding constant against human serum albumin (HSA)2001Journal of medicinal chemistry, Dec-06, Volume: 44, Issue:25
Cheminformatic models to predict binding affinities to human serum albumin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (25.00)18.7374
1990's5 (41.67)18.2507
2000's2 (16.67)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.60 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]